HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health And Wellness Industry Regulatory And Litigation News

This article was originally published in The Rose Sheet

Executive Summary

FTC ends 9-party supplement claims enforcement with three last settlements; ginkgo class action against Nature’s Bounty dismissed; and litigation dismissed when suspect sexual enhancement supplements removed from website.

You may also be interested in...



Gingko Supplement Adulteration Points To Broader Problem For FDA – CSPI

Nutrition and food safety watchdog group asks FDA to enforce against marketers of ginkgo supplements after ConsumerLab.com found that six of 10 ginkgo supplements it tested contained either less of the herb than advertised or different and cheaper plant material.

NDI Notification Costs Estimate, P&G Board: Health And Wellness Industry News

FDA NDI notification costs estimate unchanged; P&G proxy vote update favors Peltz; and trio of advertising violations for California supplement, skin care firms.

XXL Impressions Supplement Memory Claims Impress FTC As False

FTC announces agreements to settle complaints against six of nine defendants identified in an investigation of XXL Impressions' advertising for CogniPrin promoted for cognitive benefits and FlexiPrin product promoted to reduce joint paint and rebuild damaged joints and cartilage.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC066183

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel